Birmingham Clinical Trials Unit

The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the DoH

Lisa Kelly, BASIL Research Nurse at Solihull Research Showcase – celebrating BASIL trials for International Trials Day!

CReST showed that stenting as a bridge to surgery reduces stoma formation without detrimental effects in colon cancer patients with left-sided colonic obstruction #ICTD2023 @BJSurgery tinyurl.com/2p9uh8s8

@RePHILL_trial was our first trial in a prehospital setting and with the air ambulance service. Randomising 432 adults with trauma related haemorrhagic shock the trial did not show prehospital PRBC–LyoPlas resuscitation was superior to sodium chloride @TheLancetHaem #ICTD2023

Recruiting from 80 hospitals in 7 global south countries, @CheetahRct found that 1 in 8 surgical site infections could be prevented by changing gloves and instruments before fascial closure for abdominal surgery @TheLancet @NIHR_GSU #ICTD2023 tinyurl.com/4p32e4p3

The @STOPACEi_trial showed that in people with advanced and progressive chronic kidney disease, discontinuation of RAS inhibitors was not associated with difference in rate of decrease in kidney function measured using eGFR @NEJM #ICTD2023 tinyurl.com/42whfnwd

@CSTICH_Trial, which recruited 2049 women undergoing cervical cerclage, showed that a monofilament suture was not associated with improved pregnancy loss rates compared with a braided suture thread #ICTD2023 @TheLancet tinyurl.com/2p87xweb

Jointly delivered with @CRCTU the MSc in Clinical Trials provides a foundation to clinical trials covering theoretical & practical aspects of the design, conduct, analysis and interpretation of trials. Developed for a broad audience from industry, NHS Trusts & academia #ICTD2023

Published in @JCO_ASCO, FOxTROT showed that six weeks of preoperative chemotherapy for operable colon cancer can be delivered safely and provides better 2-year disease control #ICTD2023 tinyurl.com/4mmmm5sj

@Gem3Study showed in women who have a tubal ectopic pregnancy, combination treatment of gefitinib and methotrexate was not associated with a difference in need for surgical intervention compared to those who have methotrexate only @TheLancet #ICTD2023 tinyurl.com/4z48nbz6

@basil_trials showed that a best endovascular treatment first revascularisation strategy was associated with a better amputation-free survival over the vein bypass group for patients with chronic limb threatening ischaemia @TheLancet #ICTD2023 tinyurl.com/3m2tuv9e

Funded by @gatesfoundation, the @EmotiveTrial cluster randomised trial showed an immense 60% reduction in severe postpartum haemorrhage after vaginal delivery, reducing the risk of haemorrhage-related maternal death @NEJM #ICTD2023 tinyurl.com/ydn86mbz

BCTU, a UKCRC registered trials unit was 25 years old in 2022. Clinical Trial Units play a key role in the design and delivery of clinical trials. To celebrate #ClinicalTrialsDay we will be tweeting about some of the trials we have delivered over the past 12 months.

Proud beyond words of the work of colleagues from @unibirmingham @unibirm_MDS @IMSR_UoB @UoB_IAHR Partnering with the @WHO and @gatesfoundation , implementation of the intervention would have huge impact .

I’m very encouraged by the E-MOTIVE Trial results released today at #IMNHC2023 to treat postpartum hemorrhage, the #1 cause of maternal mortality. This new approach led by @unibirmingham and @WHO could drastically improve women’s chances of surviving childbirth globally. b-gat.es/3BclMsw

If anyone is interested to know more about FOxTROT, @JenSeligmann's tweetorial is essential Friday lunchtime reading!

🥁🥁🥁Tweetorial FOxTROT, the 1st ph 3 RCT of neoadjuvant chemo (NAC) in locally advanced colon cancer We report that NAC is ✅deliverable and safe ✅led to statistically significant reduction in cancer recurrence than upfront surgery A 🧵 (1/14) #crcsm ascopubs.org/doi/full/10.12…

Lots of questions emerging about #obstructionrisk in @FoxtrotStudy #NAC group❓ We've done a deep dive into this in upcoming #analysis (available Q2 2023) @BASO_ACS @RSMcoloproct 🔬 A (short) thread 🧵 @young_bjs @YouESCP @escp_tweets @ACPGBI @juliomayol @JenSeligmann (1/X)

📢 News: FOxTROT, a trial we funded, has shown that starting chemotherapy before surgery, instead of after, can significantly cut the risk of colon cancer coming back. The findings could change how doctors treat colon cancer in the NHS and around the world bit.ly/3iUSRnd

Thank you to @guardian @GdnHealthcare for featuring the FOxTROT trial results in today's publication! theguardian.com/society/2023/j…

But that's not all! FOxTROT-2 and 3 are currently active and further researching neoadjuvant chemotherapy in colon cancer. You can find out more at @FoxtrotStudy @LeedsCTRU

FOxTROT lead investigators Dion Morton, @seymourmatt1 & Richard Gray. @JenSeligmann @DrJamesGlasbey. Bengt Glimelius & Søren Laurberg. @CR_UK @yorkshirecancer @BobbyMooreFund #colorectalcancer #clinicalresearch #cancerresearch #bowelcancer #neoadjuvant #foxtrot

FOxTROT-1 trial results have been released by @JCO_ASCO! ✅Pre-operative chemotherapy for locally advanced operable colon cancer is safe ✅Improved histopathological & oncological outcomes ✅Reduced 2-year recurrence ascopubs.org/doi/10.1200/JC…